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Aim: Of this work was to determine dispersion of TGF-b, fibrosis modulating factor (bFGF and 
FGR1) and granule marker chromogranin A in case of intra-abdominal adhesion which could be 
essential factors in disease pathogenesis. Thus than could be used as possible biomarker. 
Study Design: Observational study. 
Place of Study: Institute of Anatomy and Anthropology and Department of Children Surgery, Rīga 
Stradiņš University. 











Materials and Methods: The specimens used for research were obtained from 50 patients aged 1 
to 292 days. They underwent abdominal surgery due to obstructive gut malrotation and several 
additional pathologies. Tissues were processed for bFGF, FGFR1, TGF-β and CgA by means of 
biotin-streptavidin immunohistochemistry. 
Results: In adhesion tissue bFGF positive connective tissue cells varied from a few to an 
abundant amount, but in 15 specimens no positive structure was observed. Few connective tissue 
fibers and moderate to numerous fibroblasts and macrophages contained FGFR1. A moderate 
number of TGF-β positive connective tissue fibers were observed. Some specimens also contained 
positive fibroblasts, macrophages and endotheliocytes. Few connective tissue cells contained CgA. 
A moderate correlation was observed between bFGF and FGFR1 (Spearman’s rank correlation 
coefficient = .500, P < .001) as well as between bFGF and CgA (Spearman’s rank correlation 
coefficient = .311, P = .03). 
Conclusions: The connection between the less distinct bFGF and more prominent FGFR1 proves 
the compensatory stimulation of receptors as a response on the lack of the same factor in case of 
adhesion disease. Persisting appearance of TGF-β positive structures in congenital adhesions 
indicates the continuing growth/regeneration potential of loose connective tissue. Positive CgA 
structures indicate the involvement of the neuroendocrine system in case of adhesion disease. 
 
 




Intestinal obstruction is one of the most common 
emergencies in pediatric surgery. Recent 
estimates place the incidence at 1 of 2000 live 
births [1]. Adhesive intestinal obstruction occurs, 
when pathologic bands are formed between the 
peritoneum, the small and large intestine, the 
abdominal wall and other intraabdominal     
organs [2]. Typically adhesions occur after 
intraabdominal surgery and peritonitis (regarded 
the most common complication after abdominal 
surgery [3,4], but rarely can also be congenital in 
their origin [5,6]. 
 
Congenital intra-abdominal adhesions occur due 
to disruption of the normal embryologic 
development [7]. During normal abdominal 
development, the 3 divisions of the GI tract 
(foregut, midgut, hindgut) herniate out from the 
abdominal cavity, where they then undergo a 
270º counterclockwise rotation around the 
superior mesenteric vessels. Following this 
rotation, the bowels return to the abdominal 
cavity, with fixation of the duodenojejunal loop to 
the left of the midline and the cecum in the right 
lower quadrant [8,9]. Interruption of typical 
intestinal rotation and fixation during fetal 
development can occur in a wide range of 
locations [9]. 
 
As the embryonic development is tightly 
regulated by the complex interaction of several 
morphogenetic factors, which determine and 
modulate tissue growth. Degeneration, 
innervation, angiogenesis and fibrosis, fibrosis 
modulating factors may also play a role in the 
development of congenital intestinal adhesions. 
bFGF displays mitogenic, migratory, and 
morphogenic functions. It is also known to play a 
role in organ development, organ regeneration, 
and wound healing [10]. It can stimulate smooth 
muscle proliferation [11] and influence the 
adhesion characteristics of osteoblasts [12]. 
bFGF is a potent angiogenic factor and 
endothelial cell mitogen. Although bFGF levels 
are increased in chronically inflamed tissue, but 
its role in inflammation is unclear [13]. Increased 
levels of bFGF are found in body fluids of 
patients carrying large tumor burdens, which may 
allow the tumor to stimulate blood vessel 
ingrowth [14]. 
 
FGFs execute their biological actions by binding, 
dimerizing and activating cell surface FGF 
receptors [15]. bFGF activates FGFR1 in 
cooperation with heparin or heparin sulfate 
proteoglycan to induce its pleiotropic effects in 
different tissues and organs [16]. The FGF/FGFR 
system has been implicated in a variety of 
physiological and pathological conditions. This 
includes embryonic development, tissue growth 
and remodeling, inflammation, tumor growth, and 
vascularization. FGF/FGFR signaling plays 
important functions in mesoderm formation and 
development [17]. FGFR1 activation by bFGF 
promotes catabolism and impedes anabolism 
[18]. 
 
The results of several research works indicate 
the possible role of a increased TGF-β 











TGF-β is a member of a family of dimeric 
polypeptide growth factors that includes bone 
morphogenic proteins and activins. TGF-β 
regulates the proliferation and differentiation of 
cells, embryonic development, wound healing, 
and angiogenesis. Increases or decreases in    
the production of TGF-β have been linked           
to numerous disease states, including 
atherosclerosis and fibrotic disease [21]. 
Increased TGF-β production is associated with 
adhesion development [22]. Fibroblasts obtained 
from adhesions produce greater amounts of 
TGF-β and extracellular matrix molecules than 
normal fibroblasts isolated from normal 
peritoneum [23]. TGF-β stimulates fibroblasts 
and other cells to produce extracellular-matrix 
proteins and cell-adhesion proteins (collagen, 
fibronectin, integrins). In the same time it 
decreases the production of enzymes that 
degrade the extracellular matrix (collagenase, 
heparinase, stromelysin). This increases the 
production of proteins that inhibit enzymes that 
degrade the extracellular matrix (plasminogen-
activator inhibitor type 1, tissue inhibitor of 
metalloprotease) [21]. 
 
CgA is an acidic glycoprotein belonging to a 
family of regulated secretory proteins. It is stored 
in the dense core granules of the adrenal 
medulla and in many other neuroendocrine cells 
and neurons [24]. It is known that it acts as a 
precursor of many biologically active peptides 
generated by cleavage at specific sites [25]. It is 
the major soluble protein co-stored and co-
released with catecholamines. CgA can function 
as a pro-hormone by giving rise to several 
bioactive peptides [26]. This protein is produced, 
in certain conditions also by cardiomyocytes, 
keratinocytes and granulocytes. Increased levels 
of circulating CgA have been detected in patients 
with cancer, heart failure, hypertension, atrophic 
gastritis, renal failure, giant cell artheritis, 
rheumatoid arthritis, sepsis and other 
inflammatory diseases [27]. 
 
Therefore, we suggest that bFGF, FGFR1, TGF-
β and CgA could be of importance in the 
pathogenesis of adhesions and should be 
explored as possible biomarkers. 
 
2. MATERIALS AND METHODS 
 
The specimens used for research were obtained 
from 50 patients (23 males, 27 females) aged 1 
to 292 days (Table 1) who underwent abdominal 
surgery. This was due to obstructive gut 
malrotation and several additional pathologies. 
These specimens are the property of the Institute 
for Anatomy and Anthropology of Rīga Stradiņš 
University. 
 
The tissue fragments were fixed for 24 hours in a 
mixture consisting of 2% formaldehyde and 0.2% 
picric acid in 0.1- M phosphate buffer (pH 7.2). 
These were then washed for 12 hours in 
phosphate buffer (pH 7) containing 10% sucrose. 
Then tissues were embedded in paraffin and the 
blocks of paraffinized tissues were sectioned into 
slides 6-7 µm in thickness by means of a 
microtome. 
 
2.1 Immunohistochemical Analysis 
 
Immunohistochemistry (IMH): bFGF (anti-bFGF, 
working dilution 1:200, Abcam, England), FGFR1 
(anti-FGFR1, working dilution 1:100, Abcam, 
England), TGF-β (anti-TGF-β, working dilution 
1:100, Santa Cruz, USA), CgA (anti-CgA, 
working dilution 1:100, Invitrogen, England) were 
used by biotin – streptavidin IMH [28]. 
 
Adhesion tissue tissue was deparaffinized and 
washed in alcohol and water, then washed for 10 
minutes in wash buffer (Tris-buffered saline) and 
put for 5 minutes in EDTA boiling buffer in 
microwave. When the samples had cooled down, 
they were washed twice for 5 minutes in wash 
buffer. To decrease background staining normal 
blocking serum for 20 minutes was used. All 
tissue samples were incubated with primary 
antibodies for 1 hour. Further, washing for 10 
minutes in wash buffer and incubation for 30 
minutes with LSAB+LINK with biotin related 
secondary antibodies (code K1015, 
DakoCytomation, Denmark) was performed. 
Another washing for 5 minutes in wash buffer 
was performed. The specimens were incubated 
for 25 minutes with LSAB+LINK with enzyme 
peroxidase labeled streptavidine (code K0690, 
DakoCytomation, Denmark). It was followed by 5 
minutes washing in wash buffer and 10 minutes 
processing with DAB substrate-chromogen 
system (code K3468, DakoCytomation, 
Denmark) to obtain positive structure staining in 
brown colour. Samples were then rinsed in 
running water and stained with hematoxylin. 
 
Findings were evaluated using Leica DC 300F 
camera and image processing and analysis 











































































1 M 0 SI 18 F 4 SI 35 M 56 SI 
2 F 0 D 19 F 9 D 36 F 56 SI 
3 F 0 LB 20 F 9 D 37 F 62 D 
4 M 1 SI 21 F 9 AAW 38 M 67 SI 
5 F 1 LB 22 M 9 LB 39 F 71 SI 
6 M 1 SI 23 M 14 SI 40 F 94 SI 
7 F 1 LB 24 M 15 LB 41 F 100 SI 
8 F 1 D 25 F 15 LB 42 M 103 D 
9 M 1 AAW 26 F 19 SI 43 M 108 DI 
10 M 2 SI 27 F 26 LB 44 M 129 DI 
11 M 2 SI 28 M 28 DI 45 F 130 D 
12 M 2 D 29 F 30 SI 46 F 134 SI 
13 M 2 LB 30 F 36 SI 47 F 151 SI 
14 M 2 SI 31 M 39 D 48 F 185 SI 
15 M 3 LB 32 F 41 LB 49 M 210 DI 
16 M 4 D 33 M 48 LB 50 F 292 SI 
17 F 4 LB 34 F 51 LB     
Abbreviations: SI – small intestine, DI – distal ileum, D – duodenum, LB – Ladd’s band, AAW – anterior 
abdominal wall; m – male, f – female 
 
For quantification of structures, the 
semiquantitative counting method was used. The 
designations were as follows: 
 
• 0, no positive structures found in the visual 
field; 
• 0/+, occasionally marked structures in the 
visual field; 
• +, a few positive structures in the visual 
field; 
• +/++ few to moderate positive structures in 
the visual field; 
• ++, a moderate number of marked 
structures in the visual field; 
• ++/+++, moderate to numerous number of 
positive structures in the visual field; 
• +++, a numerous number of marked 
structures in the visual field; 
• ++++, abundance of marked structures 
found in the visual field [29]. 
 
2.2 Data Analysis 
 
For data storing and processing the Microsoft 
Office Excel 2010 was used. Data analysis was 
conducted using Statistical Package for the 
Social Sciences (SPSS) program version 20.0. 
Spearman’s correlation test (rs) was used to 
evaluate correlation in between growth factors. 
Correlation was considered as weak if value rs 
was 0 – 0.3, moderate, if value rs was 0.31 – 
0.69 and strong if value rs was 0.7 – 1. Two-





bFGF was seen exclusively in fibroblasts and 
macrophages (Fig. 1A). In four cases the number 
of marked cells was abundant (++++), in five 
cases numerous (+++), but in two cases 
moderate to numerous (++/+++). Eleven 
specimens showed a moderate (++) number of 
bFGF positive cells. Two specimens showed few 
to moderate (+/++) bFGF positive cells, seven – 
few (+) positive cells. A positive reaction to bFGF 
was rarely seen for endotheliocytes and 
connective tissue fibers. Occasional (0/+) 
positive fibroblasts and macrophages were 
observed in four cases. 15 specimens didn’t 
contain any bFGF containing structures        
(Table 2). 
 
A positive reaction for FGFR1 was observed in 
fibroblasts, macrophages and connective tissue 
fibers. Rarely seen were FGFR1 positive 
endotheliocytes. A numerous (+++) number of 
FGFR1 positive fibroblasts and macrophages 











eight cases a moderate to numerous (++/+++) 
number of positive structures was marked. 
FGFR1 positive structures were mostly seen in 
moderate (++) and few to moderate (+/++) 
appearance. Few (+) fibroblasts and 
macrophages contained this factor in nine 
specimens. Occasional (0/+) positive structures 
were observed in three cases (Table 2). 
 
A numerous (+++) number of TGF-β positive 
structures was found in five specimens (Fig. 1C), 
but a moderate to numerous (++/+++) number 
was observed in 14 specimens. A moderate (++) 
number of TGF-β positive fibers was observed in 
20 cases, in another eight cases few (+) 
numbers of these structures were positive for 
TGF-β (Table 2). 
 
In two cases the number of CgA containing 
structures was numerous (+++), in another two 
cases moderate to numerous (++/+++), but in 
five cases moderate (++) (Fig. 1D and 1E). 
Seven specimens showed few to moderate 
(+/++) and 14 specimens few (+) numbers of 
CgA positive structures. In 18 specimens no 




Fig. 1. Immunoreactive structures in congenital adhesions 
A Moderate bFGF positive fibroblasts and macrophages in congenital adhesions of the four days old patient 
(bFGF IMH, x400); B Numerous FGFR1 positive fibroblasts and macrophages in congenital adhesions of the two 
days old patient (FGFR1 IMH, x400); C Numerous TGF-β positive fibroblasts, macrophages and fibers in 
congenital adhesions of a three months old patient (TGF-β IMH, x400) 
D Moderate CgA positive fibroblasts and macrophages in congenital adhesions of a four days old patient  
(CgA IMH, x250); E Moderate CgA positive epithelioid cells in congenital adhesions of a two days old patient  












Table 2. Semi-quantitative evaluation of 
immunoreactive structures 
 
 bFGF FGFR1 TGF-β CgA 
0 15 0 0 18 
0/+ 4 3 0 2 
+ 7 9 3 14 
+/++ 2 12 8 7 
++ 11 13 20 5 
++/+++ 2 8 14 2 
+++ 5 5 5 2 
++++ 4 0 0 0 
Abbreviations: bFGF – basic fibroblast growth factor, 
FGFR1 – fibroblast growth factor receptor 1, TGF-β – 
transforming growth factor β, CgA – chromogranin A, 0 
– no positive structures, 0/+ – occasionally positive 
structures, + – a few positive structures, +/++ – few to 
moderate positive structures, ++ – a moderate positive 
structures, ++/+++ – moderate to numerous positive 
structures, +++ – a numerous positive structures, 
++++ - abundant positive structures. 
 
Using the Spearman’s correlation test positive 
correlations were observed between the 
immunoreactive structures for bFGF and FGFR1 
(rs = .500; P < .001) and immunoreactive 




TGF- β is the most studied cytokine in the 
pathophysiology of adhesion development, and 
has been suggested as principal profibrotic 
mediator of this process [30]. TGF-β is a key 
regulator of extracellular matrix assembly and 
remodeling [30,31]. The action of TGF-β 
following inflammatory responses is 
characterized by increased production of 
extracellular matrix components, as well as 
mesenchymal cell proliferation, migration, and 
accumulation [32]. TGF-β causes matrix 
deposition in mesenchymal cell in culture by 
promoting expression of extracellular matrix 
genes. These suppress the activity of genes 
such as matrix metalloproteinases, which 
degrade extracellular matrix [33,30]. In our study 
TGF-β was seen in moderate to numerous 
numbers in almost all analyzed specimens. This 
is in agreement with previous studies of TGF- β 
in adhesions. The overexpression of TGF- β has 
been linked to tissue fibrosis at various sites 
throughout the body including peritoneal 
adhesion formation [34]. Elevated TGF-β 
expression in affected organs, and subsequent 
deregulation of TGF-β functions, correlates with 
an abnormal connective tissue deposition [30]. It 
has been reported, that suppression of the 
actions of TGF- β reduced adhesion formation 
[35] and anti-TGF-β agents were effective 
against postoperative inflammation and fibrosis 
[36]. 
 
The pathogenesis of congenital intra-abdominal 
adhesions could possibly be related to 
bFGF/FGFR1 signaling modification, which in 
turn could be responsible for inflammation and 
changes in vascularization and tissue 
development, as well as growth and remodeling 
processes. In one third of the analyzed 
specimens numbers of bFGF positive structures 
were low or no positive structures were detected. 
There are publications describing a possible loss 
of bFGF from the cell cytoplasm through plasma 
membrane disruptions caused by physiologically 
generated mechanical force [37]. In contrast to 
that, almost in a half of the analyzed specimens 
bFGF positive structures were observed at least 
in moderate counts and more. Studies show that 
elevated levels of bFGF are implicated in the 
pathogenesis of several diseases characterized 
by a disregulated angiogenic/inflammatory 
response. bFGF induces the expression of a 
inflammation-related genes in endothelial cells, 
including pro-inflammatory cytokines/chemokines 
and their receptors, endothelial cell adhesion 
molecules, and components of the prostaglandin 
pathway [38]. 
 
To our knowledge no studies have looked at the 
presence of FGFR1 in adhesions. We found 
moderate to numerous FGFR1 containing cells in 
intra-abdominal adhesions. Elevated expression 
of FGFR1 is believed to disrupt the interplay 
between mesenchymal and epithelial cells [39]. 
FGF/FGFR signaling plays important functions in 
the mesoderm [17]. In our study a significant 
correlation between bFGF and FGFR1 was 
detected. 
 
It is also possible that the neuroendocrine 
system is involved in the pathogenesis of 
congenital adhesions. Positive structures for CgA 
were seen in few to moderate numbers in the 
analyzed specimens. CgA is concentrated and 
stored within granules and rapidly released by 
neuroendocrine cells and neurons after an 
appropriate stimulus, this protein could be 
important for the local control of cell adhesion by 
stimulated cells [40]. CgA, locally administered to 
injured mice, can accelerate keratinocyte 
proliferation and wound healing, regulate 














Connection between the less distinct bFGF and 
more prominent FGFR1 proves the 
compensatory stimulation of receptors as a 
response on the lack of the same factor in case 
of adhesion disease. 
 
Persisting appearance of TGF-β positive 
structures in congenital adhesions indicates the 
continuing growth/regeneration potential of loose 
connective tissue. 
 
Positive CgA structures indicate the involvement 
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